Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.98 is in line with its 5-year average of 1.00, around the middle of its 5-year range (0.71–1.44).
As of the fiscal period ended Tuesday, June 30, 2026. 16.88% above its 12-month average of 0.83.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.98.
QUICK RATIO (ACID-TEST)
0.98
QUICK RATIO (ACID-TEST) AVG TTM
0.83
QUICK RATIO (ACID-TEST) AVG 3Y
0.95
QUICK RATIO (ACID-TEST) AVG 5Y
1.00
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+16.88%
CURRENT VS 3Y AVG
+2.20%
CURRENT VS 5Y AVG
-2.49%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.20
median of 747 covered companies
CURRENT VS SECTOR MEDIAN
-69.51%
vs the sector median at left
AdaptHealth Corp.
Market Cap
$794.56M
Quick Ratio (Acid-Test)
0.98
TTM Avg
0.83
3Y Avg
0.95
5Y Avg
1.00
Market Cap
$797.70M
Quick Ratio (Acid-Test)
3.86
TTM Avg
4.02
3Y Avg
3.56
5Y Avg
3.80
Market Cap
$789.07M
Quick Ratio (Acid-Test)
5.16
TTM Avg
4.89
3Y Avg
3.82
5Y Avg
4.31
Market Cap
$787.54M
Quick Ratio (Acid-Test)
1.38
TTM Avg
2.71
3Y Avg
3.18
5Y Avg
5.09
Market Cap
$810.26M
Quick Ratio (Acid-Test)
3.15
TTM Avg
4.21
3Y Avg
3.84
5Y Avg
4.13
Market Cap
$777.34M
Quick Ratio (Acid-Test)
13.29
TTM Avg
5.16
3Y Avg
5.49
5Y Avg
4.89
Market Cap
$775.07M
Quick Ratio (Acid-Test)
9.39
TTM Avg
11.79
3Y Avg
11.79
5Y Avg
11.79
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AdaptHealth Corp. (AHCO) | $794.56M | 0.98 | 0.83 | 0.95 | 1.00 |
| Apnimed, Inc. (APMD)vs › | $794.87M | N/A | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $797.70M | 3.86 | 4.02 | 3.56 | 3.80 |
| Geron Corporation (GERN)vs › | $789.07M | 5.16 | 4.89 | 3.82 | 4.31 |
| Sana Biotechnology, Inc. (SANA)vs › | $787.54M | 1.38 | 2.71 | 3.18 | 5.09 |
| InMode Ltd. (INMD)vs › | $805.59M | 7.28 | 9.00 | 9.42 | 9.03 |
| Ardelyx, Inc. (ARDX)vs › | $810.26M | 3.15 | 4.21 | 3.84 | 4.13 |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | 13.29 | 5.16 | 5.49 | 4.89 |
| Attovia Therapeutics, Inc. (ATTO)vs › | $775.07M | 9.39 | 11.79 | 11.79 | 11.79 |
| Mesa Laboratories, Inc. (MLAB)vs › | $773.13M | 1.52 | 0.88 | 1.36 | 2.75 |
Quick Ratio
0.98
Excludes inventory
Current Ratio
1.12
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.98 |
| 2026-04-10 | 0.71 |
| 2025-12-31 | 0.81 |
| 2025-09-30 | 0.86 |
| 2025-06-30 | 0.82 |
| 2025-03-31 | 1.07 |
| 2024-12-31 | 1.09 |
| 2024-09-30 | 1.00 |
| 2024-06-30 | 0.94 |
| 2024-03-31 | 1.11 |
| 2023-12-31 | 1.00 |
| 2023-09-30 | 1.05 |
| 2023-06-30 | 0.99 |
| 2023-03-31 | 0.97 |
| 2022-12-31 | 1.00 |
| 2022-09-30 | 1.08 |
| 2022-06-30 | 1.15 |
| 2022-03-31 | 1.16 |
| 2021-12-31 | 1.09 |
| 2021-09-30 | 1.44 |
| 2021-06-30 | 0.84 |
| 2021-03-31 | 0.83 |
| 2020-12-31 | 0.72 |
| 2020-09-30 | 1.39 |
| 2020-06-30 | 0.93 |
| 2020-03-31 | 0.92 |
| 2019-12-31 | 1.09 |
| 2019-09-30 | -4.22 |
| 2019-06-30 | -5.49 |
| 2019-03-31 | 0.93 |
| 2018-12-31 | -9.39 |
| 2018-09-30 | 2.86 |
| 2018-06-30 | 13.06 |
| 2018-03-31 | 16.75 |
